Supposed connections between Actos and bladder cancer have been the subject of research for several years. According to the Journal for the National Institute of Cancer Research, patients taking thiazolidinediones, for five or more years may be three times as likely to develop cancer than... Read More

The first generic version of the type 2 diabetes drug Actos was approved by the Food and Drug Administration (FDA) on August 17, 2012. The generic drug will be manufactured by Mylan Pharmaceuticals, who gained approval for the 15 mg, 30 mg, and 40 mg... Read More

The widow of a man who died of bladder cancer from Actos has filed a lawsuit against Takeda Pharmaceuticals, maker of the diabetes drug. The plaintiff, Nancy Harber, filed her lawsuit Nancy Harber and Thomas Harber vs. Takeda Pharmaceuticals on August 10, 2012 in the... Read More

On October 1, 2009, the U.S. Judicial Panel established the Chantix multidistrict litigation (MDL). Since its inception, over 275 cases have been consolidated into the MDL. Due to the growing number against the manufacturer of Chantix, Pfizer, the Panel found that there were common issues... Read More

A new lawsuit against the manufacturer of the diabetes drug Actos, Takeda Pharmaceuticals America, Inc., was filed on August 1, 2012, in the Circuit Court of Cook County, Illinois. The plaintiff, Rodkey Dale Roberts, alleges that Takeda did not adequately warn patients and medical practitioners... Read More

A Connecticut woman recently filed a lawsuit against Takeda Pharmaceuticals stating that three years after being diagnosed with bladder cancer, she first learned that the diabetes drug Actos (pioglitazone) had been linked to the life-threatening illness. Her lawsuit was filed on August 1, 2012 in... Read More

David Taylor, an Idaho resident, seeks to hold the manufacturer of Actos—Takeda Pharmaceuticals—liable for his injuries by filing a lawsuit against the company in the Circuit Court of Cook County, Illinois. The suit was filed on August 7, 2012. Taylor claims that Takeda concealed their... Read More

Kenneth Easton, Jr. adopted the short form complaint in order to join ongoing litigation related to the smoking cessation drug Chantix. The consolidated litigation is taking place in the United States' District Court for the Northern District of Alabama, Southern Division, and the Florida resident... Read More